Search
for

    Sort by

    Research 961–990 of 1000+

    1. Assessment of the Ability of the ChatGPT-5 Model to Pass the Endocrinology Specialization Exam Cureus · 2025 · 1 citations
    2. Evaluation of Therapeutic Potential of a Selective 5α-reductase Inhibitor against Glioblastoma: Molecular Docking and In Vitro Insights Cell Biochemistry and Biophysics · 2025 · 1 citations
    3. Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional‐comparative study Journal of Cosmetic Dermatology · 2022 · 1 citations
    4. Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models Frontiers in Pharmacology · 2022 · 1 citations
    5. A comparative study of efficacy of 5% minoxidil and 5% minoxidil plus platelet-rich plasma in same patient for treatment of androgenetic alopecia Journal of Cutaneous and Aesthetic Surgery · 2022 · 1 citations
    6. Relative efficacy of minoxidil and 5-alpha-reductase inhibitors in the treatment of male androgenetic alopecia: protocol for a network meta-analysis study 2021 · 1 citations
    7. Use of the drug Wolvit® (biotin 5 mg) in treatment of defuse telogenous alopecia Ukraïnsʹkij žurnal dermatologìï, venerologìï, kosmetologìï · 2018 · 1 citations
    8. The effect of topical finasteride 0.5% on the outcome of diode laser therapy in the treatment of excess facial hairs in the women with hirsutism. PubMed · 2016 · 1 citations
    9. Comparative Study of Efficacy of Topical Minoxidil 5% and Combination of Topical Minoxidil 5%, Topical Azelaic Acid 1.5% and Topical Tretinoin 0.01% on the Basis of Dermoscopic Analysis in Androgenetic Alopecia MVP journal of medical science · 2015 · 1 citations
    10. Improvement of Tissue Survival of Skin Flaps by 5α-Reductase Inhibitors: Possible Involvement of Nitric Oxide and Inducible Nitric Oxide Synthase PubMed · 2015 · 1 citations
    11. Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate. PubMed · 2013 · 1 citations
    12. Trichilemmoma.Features of keratin expression in CS-5 trichocyst system tumors. Skin Cancer · 1995 · 1 citations
    13. EFFICACY AND SAFETY OF ORAL MINOXIDIL 2.5 MG ONCE DAILY IN MEN WITH ANDROGENETIC ALOPECIA: PROSPECTIVE SINGLE-CENTRE STUDY International Journal of Scientific Research · 2026
    14. Review of the Efficacy of Topical 5-Alpha Reductase Inhibitors for the Treatment of Androgenetic Alopecia Journal of Drugs in Dermatology · 2026
    15. Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study Research Square · 2026
    16. Online Discussions About Alopecia Areata in 5 Arabian Gulf Countries: Social Media Listening Study JMIR Dermatology · 2026
    17. Comparative study between topical minoxidil 5% and oral spironolactone versus topical minoxidil 5% and oral dutasteride in the treatment of women with androgenic alopecia International Journal of Medical Arts · 2026
    18. Evaluation of the efficacy of topical spironolactone 5% solution versus minoxidil 5% solution vs combination of topical spironolactone 5% and minoxidil 5% solutions in female pattern hair loss International Journal of Medical Arts · 2026
    19. Conference Abstracts from the 12th Asian Scientific Meeting of Pediatric Dermatology in Manila, Philippines, 5–7 November 2025 Asian journal of pediatric dermatology. · 2026
    20. In Vivo and In Vitro Evaluation of PTeCA (1H‐Pyrrole‐2,3,4,5‐Tetracarboxylic Acid) in Hair Matrix as a Marker for Oxidative Cosmetic Treatment Drug Testing and Analysis · 2026
    21. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    22. Comparative evaluation of eyebrow rejuvenation using hibiscus oil 5% (w/v) with and without Gua-sha: A split face randomized control Trial National Journal of Maxillofacial Surgery · 2026
    23. Efficacy and Safety of Mesotherapy With 0.5% Minoxidil Versus Topical 2% Minoxidil for Female Androgenetic Alopecia: A Randomized Controlled Trial Dermatologic Therapy · 2026
    24. Suicidal ideation in patients undergoing treatment with 5α-reductase inhibitors Instituto Politécnico do Porto · 2025
    25. COMPARATIVE STUDY OF TWO CONCENTRATIONS (2.5MG/ML AND 5 MG/ML) OF INTRALESIONAL TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF ALOPECIA AREATA Tạp chí Da liễu học Việt Nam · 2025
    26. Efficacy and safety of oral minoxidil 5 mg in male patients with androgenetic alopecia. The Professional Medical Journal · 2025
    27. COMPARATIVE STUDY BETWEEN EFFICACY OF MINOXIDIL (5%) AND PLATELET RICH PLASMA IN THE TREATMENT OF ANDROGENETIC ALOPECIA IN MALES International Journal of Scientific Research · 2025
    28. COMPARISON OF THERAPEUTIC EFFICACY OF MICRONEEDLING WITH PLATELET-RICH PLASMA PLUS 5% MINOXIDIL AND 5% MINOXIDIL ALONE IN ANDROGENETIC ALOPECIA Journal of Population Therapeutics and Clinical Pharmacology · 2025
    29. A COMBINATION STUDY BETWEEN TOPICAL 5%MINOXIDIL AND TOPICAL PROCAPIL IN MEN WITH ANDROGENIC ALOPECIA Zenodo (CERN European Organization for Nuclear Research) · 2025
    30. A COMBINATION STUDY BETWEEN TOPICAL 5%MINOXIDIL AND TOPICAL PROCAPIL IN MEN WITH ANDROGENIC ALOPECIA Zenodo (CERN European Organization for Nuclear Research) · 2025